Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Citicoline in Neonatal Hypoxic Ischemic Encephalopathy
NCT07763145Not yet recruiting
- Sponsor
- Khyber Girls Medical College
- Start
- Sep 2026
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
Randomised trial of citicoline in hypoxic-ischemic encephalopathy (HIE) (2 arms), sponsored by Khyber Girls Medical College. Primary endpoints: Sarnat and Sarnat scoring at 72 hours and Cerebral Resistive Index at 72 hours. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
citicoline
03
Conditions
hypoxic-ischemic encephalopathy (HIE)
Beyond the preview
Go deeper on NCT07763145.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07763145.